Cite
Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel.
MLA
Linderholm, B. K., et al. “Angiogenic Factors in Relation to Clinical Effect in a Phase II Trial of Weekly Paclitaxel.” Breast (Edinburgh, Scotland), vol. 22, no. 6, Dec. 2013, pp. 1142–47. EBSCOhost, https://doi.org/10.1016/j.breast.2013.07.041.
APA
Linderholm, B. K., Lidbrink, E., Tallroth, E., Einbeigi, Z., Svensson, H., von Wachenfeldt, A., Norberg, B., Carlsson, L., Olsson, M. E., Bergh, J., Wilking, N., & Hatschek, T. (2013). Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel. Breast (Edinburgh, Scotland), 22(6), 1142–1147. https://doi.org/10.1016/j.breast.2013.07.041
Chicago
Linderholm, B K, E Lidbrink, E Tallroth, Z Einbeigi, H Svensson, A von Wachenfeldt, B Norberg, et al. 2013. “Angiogenic Factors in Relation to Clinical Effect in a Phase II Trial of Weekly Paclitaxel.” Breast (Edinburgh, Scotland) 22 (6): 1142–47. doi:10.1016/j.breast.2013.07.041.